The ADDMI Interest Group addresses the pipeline issue for drug development, encourages and fosters multidisciplinary research towards advancing drug development through Molecular Imaging (ADDMI), provides a platform for productive discussions around drug development through molecular imaging and its challenges, pursues a common goal of developing ADDMI, helps facilitate the successful development of ADDMI, provides a platform to address clinical manufacturing issues and Phase 1 clinical trials, and establishes ADDMI/WMIS as a ‘central body’ to help address regulatory and reimbursement issues related to ADDMI.
WMIS invites you to find your place to grow, collaborate and make a difference – join the ADDMI Interest Group today.
Members: Interest Groups are open to current WMIS Members. There is an annual Interest Group membership fee of $20 which is requested to help offset administrative costs. To join an interest group, please click the button below.
If you are not a current WMIS member, please click the button below and create a new profile to join WMIS and join interest groups.
Members of affiliate MI Societies who wish to join WMIS Interest Groups should contact Sylvia Anderson at email@example.com, or call 310-215-9730 for assistance.
To globally engage and advance discovery and clinical application of molecular imaging approaches for the development of molecular imaging based companion diagnostics for therapeutics.